ARTICLE | Clinical News
IMA950: Phase I data
May 12, 2014 7:00 AM UTC
immatics reported data from an open-label, U.K. Phase I trial in 45 patients with newly diagnosed glioblastoma showing that IMA950 plus standard of care (SOC) surgery and concomitant or adjuvant chemo...